Rodman & Renshaw Reiterates Buy Rating With a $6.00 Price Target for DS Healthcare Group, Inc.
March 02, 2016 10:33 ET
|
DS Healthcare Group, Inc.
POMPANO BEACH, Fla., March 02, 2016 (GLOBE NEWSWIRE) -- Senior Biotechnology Analyst, Raghuram Selvaraju, Ph.D., of Rodman & Renshaw, (a unit of H.C. Wainwright & Co.) has reiterated his buy...
Stevia First Corp. to Present in New York and Las Vegas in September
September 08, 2014 09:00 ET
|
Stevia First Corporation
SACRAMENTO, CA--(Marketwired - Sep 8, 2014) - Stevia First Corp. (OTCQB: STVF) ("Stevia First" or the "Company"), an agricultural biotechnology company based in California's Central Valley growing...
PositiveID Corporation to Present at the Rodman & Renshaw Global Investment Conference
September 02, 2014 09:00 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Sept. 2, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced that its...